Skip to main content
Caplight Logo









SmartCella Holding AB

SmartCella Holding AB

Private
TullingeHealthcare & Life Scienceshttps://www.smartcella.com/

Last Round

Private Equity

Jul 8, 2024

Est. Valuation

$595.93M

Total Funding Raised

$54.18M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

SmartCella Holding AB is a biotechnology company that provides first-in-class delivery platforms for targeted therapies, including the FDA-cleared Extroducer® device and a proprietary stem cell platform for mRNA therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

drug delivery platformtargeted drug deliveryendovascular catheterregenerative medicinecell therapymedical device licensingcell and gene therapyFDA 510(k) clearedmRNA therapystem cell therapyCGT deliverygene therapy deliverymicro-infusion catheterheart failure treatmentParkinson's disease treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SmartCella Holding AB Comparables

Compare SmartCella Holding AB with similar companies based on industry and business-model similarity.

SmartCella Holding AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bayer AG
70%
Mercator MedSystems, Inc.
67%
BioCardia Inc
64%

SmartCella Holding AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 8, 2024
VC RoundSep 27, 2021

Key People

Founding team and executive leadership

Ricardo Baptista

Chief Technology Officer of SmartCella and Head of Procella Therapeutics

Executive Team

Johan Rugfelt

COO

Executive Team

SmartCella Holding AB Investors

Notable investors and investment history

SmartCella Holding AB investors
InvestorRounds
Handelsbanken FonderPrivate Equity
AP4 (The Fourth Swedish National Pension Fund)VC Round, Private Equity
AMF TjänstepensionVC Round, Private Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 40, 63% of headcount.

  • Jul 13, 2026

    Open roles increased to 17, representing 27% of headcount.

SmartCella Holding AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SmartCella Holding AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SmartCella Holding AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersTullinge
Employee Range63
Year Founded2014
Last FundingJul 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.